G. Kaishibayeva

LRRK2 Mutations and Asian Disease-Associated Variants in the First Parkinson's Disease Cohort from Kazakhstan

H. Houlden, E. Zholdybayeva, M. Rizig, 2020, Parkinson's disease.

Electro-neurophysiological criteria of efficiency of pathogenetic therapy in diabetic polyneuropathy

G. Kaishibayeva, L. Kuzina, 2017 .

Vitamin D deficiency in Kazakhstan: Cross-Sectional study

A. Chibisova, Yu O Semenova, V. Lokshin, 2019, The Journal of Steroid Biochemistry and Molecular Biology.

A glimpse of the genetics of young‐onset Parkinson’s disease in Central Asia

J. Hardy, H. Houlden, J. Vandrovcova, 2021, Molecular genetics & genomic medicine.

Physical treatment of Parkinson's disease

G. Kaishibayeva, A. Karimova, G. Amraeva, 2020 .

Parkinson's Disease in Central Asian and Transcaucasian Countries: A Review of Epidemiology, Genetics, Clinical Characteristics, and Access to Care

H. Houlden, M. Rizig, T. Khaibullin, 2019, Parkinson's disease.

Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

Chelsea X Alvarado, D. Hernandez, M. Nalls, 2023, The Lancet Neurology.

[First cases of Pompe's disease in Kazakhstan].

N. Zharkinbekova, G. Kaishibayeva, G. Mukhambetova, 2017, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.